Peptide Research Comparisons
Side-by-side comparative analyses of research peptides based on peer-reviewed clinical data, mechanisms of action, and efficacy outcomes.
Semaglutide vs Tirzepatide
Research indicates that Tirzepatide, a dual GIP/GLP-1 receptor agonist, demonstrates superior weight loss efficacy compared to Semaglutide, a GLP-1-only agonist, in head-to-head clinical trials. The S...
Retatrutide vs Tirzepatide
Retatrutide, a first-in-class triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors, demonstrates unprecedented weight loss efficacy in clinical trials—up to 24.2% body weight r...
Retatrutide vs Semaglutide
Retatrutide's triple receptor mechanism (GLP-1/GIP/Glucagon) achieves significantly greater weight loss than Semaglutide's single GLP-1 pathway—24.2% vs 14.9% body weight reduction in clinical trials....
AOD-9604 vs Semaglutide
AOD-9604, a modified fragment of human growth hormone (amino acids 176-191), and Semaglutide, a GLP-1 receptor agonist, represent fundamentally different approaches to fat metabolism research. AOD-960...
BPC-157 vs TB-500
BPC-157 and TB-500 are two peptides extensively studied in preclinical research for their potential influence on tissue repair processes, with complementary but distinct mechanisms. BPC-157, a stable ...
Semax vs Selank
Semax and Selank, both developed in Russia for clinical use, represent complementary approaches to cognitive and emotional regulation through peptide therapeutics. Semax, derived from ACTH (4-10), pri...
CJC-1295 vs Ipamorelin
CJC-1295 and Ipamorelin represent two complementary mechanisms for stimulating growth hormone release, which is why they are frequently combined in research settings. CJC-1295, a GHRH (growth hormone ...
Epithalon vs FOXO4-DRI
Epithalon and FOXO4-DRI represent two distinct approaches to cellular anti-aging research. Epithalon, a synthetic tetrapeptide based on pineal gland epithalamin, activates telomerase to maintain or ex...
GHK-Cu vs BPC-157
GHK-Cu and BPC-157 are two of the most researched peptides for tissue repair, with distinct but potentially complementary mechanisms. GHK-Cu, a naturally occurring copper-binding tripeptide, excels in...
GHRP-6 vs GHRP-2
GHRP-6 and GHRP-2 are both hexapeptide growth hormone releasing peptides that stimulate GH release through the ghrelin receptor (GHS-R1a), but differ significantly in selectivity and side effect profi...
Sermorelin vs CJC-1295
Sermorelin and CJC-1295 are both GHRH analogs that stimulate pituitary GH release through the GHRH receptor, but differ dramatically in pharmacokinetics. Sermorelin is the natural GHRH (1-29) fragment...
Hexarelin vs Ipamorelin
Hexarelin and Ipamorelin represent opposite ends of the GHRP spectrum: maximum potency versus maximum selectivity. Hexarelin is the most potent GHRP for acute GH release but carries significant off-ta...
BPC-157 vs KPV
BPC-157 and KPV represent different approaches to tissue healing and inflammation control, with overlapping applications in gastrointestinal research. BPC-157, a stable gastric pentadecapeptide, promo...
Liraglutide vs Semaglutide
Semaglutide demonstrates superior weight loss efficacy compared to Liraglutide in both clinical trial data and head-to-head comparisons, with once-weekly Semaglutide 2.4 mg (Wegovy) producing approxim...
Thymosin Alpha-1 vs LL-37
Thymosin Alpha-1 and LL-37 are two well-characterized immune-modulating peptides with complementary but distinct mechanisms. Thymosin Alpha-1 is a thymic hormone that primarily modulates adaptive immu...
Ipamorelin vs Sermorelin
Ipamorelin and Sermorelin represent two distinct mechanistic approaches to growth hormone stimulation. Ipamorelin is a GHRP (ghrelin receptor agonist) that amplifies GH pulse amplitude; Sermorelin is ...
Epithalon vs Thymosin Alpha-1
Epithalon and Thymosin Alpha-1 represent distinct but complementary approaches to age-associated decline. Epithalon is a pineal tetrapeptide studied for telomere elongation and telomerase activation; ...
PT-141 vs Melanotan II
PT-141 (Bremelanotide) and Melanotan II are both cyclic heptapeptide analogs of alpha-MSH acting on melanocortin receptors, but with different selectivity profiles and regulatory status. PT-141 receiv...
Tirzepatide vs CagriSema (Cagrilintide + Semaglutide)
Tirzepatide and CagriSema (cagrilintide + semaglutide) represent two distinct multi-receptor approaches to obesity pharmacotherapy. Tirzepatide's SURMOUNT-1 trial achieved 22.5% body weight loss at th...
Semax vs Dihexa
Semax and Dihexa are two of the most potent cognitive-enhancing peptides in preclinical research, though through entirely different mechanisms. Semax is an ACTH(4-7) analog registered in Russia that s...
GHK-Cu vs Epithalon
GHK-Cu and Epithalon are two well-characterized anti-aging peptides targeting different biological mechanisms. GHK-Cu is a naturally occurring copper tripeptide that modulates gene expression, promote...
BPC-157 vs LL-37
BPC-157 and LL-37 are both studied for wound healing but through distinct mechanisms: BPC-157 promotes tissue repair through angiogenesis, fibroblast activation, and nitric oxide modulation; LL-37 pro...
BPC-157 vs Ipamorelin
BPC-157 and Ipamorelin target entirely different physiological systems: BPC-157 is a tissue repair peptide derived from gastric juice that promotes healing through angiogenesis and fibroblast activati...
Semax vs PT-141
Semax and PT-141 share ACTH/alpha-MSH origin but represent pharmacologically distinct agents. Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is an ACTH(4-7) analog registered in Russia as a cognitive and neuropr...